USL311
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for USL311, covering 2021-07-23 to 2021-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]